# EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality

> **NCT03987633** · — · RECRUITING · sponsor: **Future Genetics Limited** · enrollment: 200000 (estimated)

## Conditions studied

- Atrial Fibrillation
- Coronary Heart Disease
- Cardiovascular Diseases
- Heart Failure
- Hypertension
- Peripheral Arterial Disease
- Stroke, Ischemic
- Asthma
- Chronic Obstructive Pulmonary Disease
- Obesity
- Cancer
- Chronic Kidney Diseases
- Diabetes Mellitus
- Dementia
- Depression
- Epilepsy
- Mental Health Disorder
- Rheumatoid Arthritis
- Blood Pressure
- Breast Cancer Risk
- Prostate Cancer
- Lung Cancers

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03987633
- **Lead sponsor:** Future Genetics Limited
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-02-01
- **Primary completion:** 2028-02-01
- **Final completion:** 2030-02-01
- **Target enrollment:** 200000 (ESTIMATED)
- **Last updated:** 2025-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03987633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03987633, "EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03987633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*